Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL — Stella

Home/DLBCL - Diffuse Large B Cell Lymphoma/Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

View on ClinicalTrials.gov

Recruiting

Back to DLBCL - Diffuse Large B Cell Lymphoma trials

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Trial locations(1 site)

Egypt

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Cairo Governorate

Key details

Sponsor

Ain Shams University

Enrollment target

~40 participants

Started

May 2025

Primary completion

May 2026

Age range

18 Years – 65 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.